Dianthus Therapeutics Inc. (DNTH) — Cash Flow-to-Debt Ratio
Dianthus Therapeutics Inc. (DNTH) has a Cash Flow-to-Debt Ratio of -0.63x as of March 2026, meaning its operating cash flow of $-28.86 Million could theoretically repay -1% of its total liabilities ($45.57 Million) in one year. Explore DNTH long-term investment intensity to see how much of total assets are deployed in long-term investments.
CF-to-Debt Ratio
Operating Cash Flow
Total Liabilities
Data as of
Dianthus Therapeutics Inc. Cash Flow-to-Debt Ratio (2016–2025)
Historical debt coverage capacity for Dianthus Therapeutics Inc. across 10 annual periods. Also explore Dianthus Therapeutics Inc. (DNTH) total assets for the complete picture of this company's asset base.
Annual Cash Flow-to-Debt Ratio for Dianthus Therapeutics Inc. (2016–2025)
Year-by-year debt coverage analysis for Dianthus Therapeutics Inc.. For market capitalisation and broader financial context, see DNTH market cap overview.
| Year | CF-to-Debt Ratio | Operating CF (USD) | Total Liabilities | YoY Change |
|---|---|---|---|---|
| 2025 | -3.44x | $-129.06 Million | $37.52 Million | ▲ +5.3% |
| 2024 | -3.63x | $-78.18 Million | $21.53 Million | ▼ -3.8% |
| 2023 | -3.50x | $-36.86 Million | $10.54 Million | ▼ -13.8% |
| 2022 | -3.07x | $-29.07 Million | $9.45 Million | ▲ +10.8% |
| 2021 | -3.45x | $-59.53 Million | $17.26 Million | ▲ +4.6% |
| 2020 | -3.61x | $-64.02 Million | $17.71 Million | ▼ -28.6% |
| 2019 | -2.81x | $-57.10 Million | $20.32 Million | ▲ +21.7% |
| 2018 | -3.59x | $-41.89 Million | $11.66 Million | ▲ +33.2% |
| 2017 | -5.37x | $-22.26 Million | $4.14 Million | ▼ -89.3% |
| 2016 | -2.84x | $-6.53 Million | $2.30 Million | — |